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Process analytical technology 
Quality-by-design 
Biophotonics 
A B S T R A C T   
Freeze-drying is the most widespread method to preserve protein drugs and vaccines in a dry form facilitating 
their storage and transportation without the laborious and expensive cold chain. Extending this method for the 
preservation of natural biomaterials and cells in a dry form would provide similar benefits, but most results in the 
domain are still below expectations. In this review, rather than consider freeze-drying as a traditional black box 
we “break it” through a detailed process thinking approach. We discuss freeze-drying from process thinking 
aspects, introduce the chemical, physical, and mechanical environments important in this process, and present 
advanced biophotonic process analytical technology. In the end, we review the state of the art in the freeze- 
drying of the biomaterials, extracellular vesicles, and cells. We suggest that the rational design of the experi-
ment and implementation of advanced biophotonic tools are required to successfully preserve the natural bio-
materials and cells by freeze-drying. We discuss this change of paradigm with existing literature and elaborate on 
our perspective based on our new unpublished results.   
1. Introduction 
Biomaterials can be defined as “natural or synthetic materials that are 
suitable for introduction into living tissue especially as a part of medical 
device”. While natural biomaterials self-evidently comprise cells or their 
derivatives, synthetic biomaterials include non-natural polymers and 
even metals as in the case of artificial joints. Combined with cells, bio-
materials have introduced a new dimension into multiple research areas 
such as reparative treatments, wound healing, and cancer treatment 
[1–5]. However, besides the advantages of combinatory treatments, 
biomaterials and cells introduce challenges in their long-term preser-
vation: Typically, natural biomaterials and cells are cryopreserved in 
− 80 ◦C ultra-freezers or liquid nitrogen tanks for their long-term stor-
age. Even though widely accepted and commonly used, these cryo-
preservation methods require constant maintenance to keep the 
valuable materials intact. Power failure or failure to add liquid nitrogen 
can result in the loss of samples, working hours, and money. Maintaining 
large sample libraries cryopreserved does not only occupy large space 
with freezers and back-up freezers but also creates continuous costs in 
the terms of used electricity and liquid nitrogen. The cryopreserved 
materials are also exposed to the risk of cross-contamination when 
stored in liquid nitrogen [6]. Furthermore, the logistics of cryopreserved 
substances might be challenging, as can be seen with for example the 
vaccine for SARS-COV-2 [7]. 
Freeze-drying is a pliable method to counter these challenges. As a 
desiccation method, freeze-drying is especially suitable for the preser-
vation of heat-sensitive substances such as protein drugs and vaccines, to 
formulate drugs for parenteral administration or to manufacture scaf-
folds. The freeze-drying process can be divided into three main steps: 1) 
Freezing (solidification of a sample), 2) primary drying (sublimation of 
frozen water) and 3) secondary drying (removal of unfrozen water) 
(Fig. 1). Due to the highly energetic nature of the constitutive processes, 
freeze-drying causes compositional, thermal, and pressure changes in 
the proximity of the biomaterials and cells to preserve, rendering the 
processed samples vulnerable to denaturation, osmotic imbalance, and 
mechanical stress. Studying the conditions the biological materials are 
subjected to during the freeze-drying process requires following the 
changes in chemical, physical, and mechanical environments locally 
which is extremely challenging. Tackling these hurdles requires ap-
proaches such as process analytical technology (PAT), and biophotonic 
tools like Raman and near-infrared (NIR) spectroscopy. 
The lack of applied advanced detection technologies and the success 
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with simpler substances, like proteins, has led into a situation where old 
manners are directly applied into more labile formulations. The impact 
of the processing steps on the composition and physicochemical condi-
tions around cells has been, until now, mostly done indirectly by 
comparing the viability and/or integrity of the biological species before 
and after processing. If these results are of indisputable relevance, they 
provide limited information to rationalize freezing and drying processes. 
It is a black box! Accepting the black box promotes trial-and-error ap-
proaches when designing the freeze-drying process for new natural 
biomaterials or cells. 
We discuss in this review the advances and bottlenecks of freeze- 
drying of natural biomaterials and cells while incorporating Quality 
by Design and PAT perspectives in our discussion. We believe that 
addressing the sample through changes in chemical, physical, and me-
chanical environments provides new insights into freeze-drying as a 
process while offering new tools to optimize the conservation of com-
plex natural biomaterial and cell entities. 
2. Quality by design and design spaces in freeze-drying of 
biomaterials and cells 
Unfortunately, for many decades the formulation and process opti-
mization have based on trial-and-error in drug development. To 
implement a more structured approach to process optimization, the 
International Conference of Harmonization has introduced new guide-
lines for science-based manufacturing of final dosage forms [11–13]. 
The new concept of manufacturing drugs is gathered under the umbrella 
of Quality-by-Design (QbD) ideology. QbD is defined as”A systematic 
approach to development that begins with predefined objectives and empha-
sizes product and process understanding and process control, based on sound 
science and quality risk management.” [11] The flowchart of necessary 
steps required for systematic implementation of QbD is presented in 
Fig. 2. 
The first step in the QbD process is to define the Quality Target 
Product Profile (QTPP), meaning a prospective summary of the quality 
characteristics of a drug product that ideally will be achieved to ensure the 
desired quality, taking into account the safety and efficacy of the drug 
product. [11]. The next step is to define Critical Material Attributes 
Fig. 1. Freeze-drying is a multistep process in which the sample is first frozen (1. Freezing), then the frozen water (ice) is sublimated under vacuum (2. Primary 
drying), after which temperature is elevated and unfrozen water is desorbed (3. Secondary drying). The product is a porous dry product that can be stored unfrozen 
preferably at room temperature for years (4. Storage). Rational design of the experiment and careful control of each step is required to obtain the final product of high 
quality. In the freeze-drying process, the most important parameters that can be controlled are the shelf temperature of the freeze-drying machine, pressure in the 
freeze-drying chamber, and time used for the freeze-drying process. Since the temperature of the sample determines the rate of sublimation, which directly correlates 
to the time required to obtain a dry enough sample, controlling and monitoring the temperature of the sample during the entire process is highly important. Modified 
from: Franks (2008) [8], Pikal et al. (1984) [9], and Kawasaki et al. (2019) [10]. 
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(CMAs) and Critical Process Parameters (CPPs) which affect Critical 
Quality Attributes (CQAs) and ultimately to the QTPP. Typically, the 
definition of attributes and parameters is done by a multidisciplinary 
team of experts in a process initiated by the identification of relevant 
CMAs, CPPs, and CQAs. To facilitate the task, various standardized 
quality risk management tools such as Ishikawa chart [14], Failure 
Mode Effects Analysis [15], Fault Tree Analysis, Risk Ranking, and 
Filtering are commonly utilized. To summarize, typically risks are 
identified, analyzed, and evaluated with the following questions: I) 
What might go wrong? II) What is the likelihood it will go wrong? III) 
What are the consequences (severity)? Based on the risk assessment, 
decisions have to be made (Risk Control) whether the risk needs to be 
reduced or even eliminated due to its severity and probability (Risk 
Reduction) or is the risk in accepted level, harmless and unlikely (Risk 
Acceptance). As a final result of the risk assessment, CMAs and CPPs 
which have to be controlled, and CQAs which have to be monitored have 
been identified. 
The next task in QbD approach is to figure out what are the re-
lationships of selected CMAs and CPPs on CQAs and subsequently to the 
QTPP. This can be done scientifically using Design of Experiment (DoE) 
meaning a structured, organized method for determining the relationship 
between factors affecting a process and the output of that process [11]. The 
DoE exercise results in statistically significant relationships of CMAs and 
CPPs on CQAs that can be modeled using Principal Component Analysis, 
Partial Least Square Projection, or other more sophisticated modeling 
tools like Artificial Neural Networks. Reliable DoE models create the 
foundation of establishing Design Space (DS), in which the multidimen-
sional combination and interaction of input variables (e.g., material attri-
butes) and process parameters that have been demonstrated to provide 
assurance of quality [11]. DS is just one space in the spectrum of specific 
spaces to seek the deeper process understanding in QbD thinking. 
Multidimensional space consists of multiple spaces inside each other, 
and the largest space is an operational space, typically defined by the 
constraints of specifications of equipment like temperature range, 
pressure/vacuum range, load capacity, and dimensions of the equip-
ment. Inside operational space is Knowledge Space (KS), and the 
boundaries of KS are defined by a priori information of process or 
equipment, or boundaries can be derived from fundamental equations 
describing the performance of process or equipment. Practically, in 
freeze-drying, choked flow conditions can be calculated as a function of 
vacuum and shelf temperature settings and the dimensions of freeze- 
dryer [16]. Inside of KS is the DS, which defines the CMAs and CPPs 
yielding the required quality of the product. From the process control 
perspective, often inside of DS is defined Control Space (CS) defining 
boundaries that trigger control actions in CMAs and CPPs, if CQA(s) 
crosses the said boundaries. 
DS and KS are subjected to continuous verification and improvement 
with the gained data and process understanding. Several control stra-
tegies based on empirical (DoE) or first principle models to keep CQAs 
within DS exist, but they are out of the scope of this review. The suc-
cessful implementation of the QbD approach to the pharmaceutical 
processes requires monitoring that CQAs stay within the DS, achievable 
with PAT tools used in real-time and in-line manner/fashion. Commonly 
used PAT tools for freeze-drying are covered in Chapter 4. It is worth 
noting already here that no previous study of freeze-drying biomaterials 
and cells utilized QbD ideology in their experiments. We provide here 
suggestions on how the QbD ideology can be useful in the freeze-drying 
of biomaterials and cells, and how a change of paradigm is needed. The 
state of the art of freeze-drying of biomaterials and cells is discussed in 
more detail in chapter 5. 
2.1. Freezing: Solidification of sample 
In the freezing step, the temperature of the sample is lowered below 
its freezing point to solidify the sample. The freezing of water solution, 
or crystallization in general, consists of two steps: 1) nucleation and 2) 
the growth of nuclei to the macroscopic crystals. The driving force of 
nucleation is mainly defined by supercooling. As the temperature drops 
below the freezing point of the solution, the probability to form ther-
modynamically favorable ice clusters, which act as nuclei for ice crys-
tallization, grows. There are several ways to induce ice nucleation in the 
samples to reduce variation between ice nucleation temperatures [17]. 
Upon nucleation, ice crystals begin to grow. In the context of freezing 
biological entities, ice crystal growth is a double-edged sword. On the 
one hand, it allows the creation of ice crystals that will define the bio-
material's macro-porosity, essential for fluid and gas diffusion and cell 
colonization. On the other hand, ice growth poses a major concern in 
terms of the integrity of the biological entities. Moreover, the freezing 
step affects directly the following steps of the freeze-drying cycle - larger 
supercooling (lower nucleation temperature) favors faster formation of 
nuclei (homogenous nucleation) which leads to the larger number of 
smaller crystals with large surface area. This causes longer primary 
drying time due to the high dry layer resistance but higher unfrozen 
water desorption rate during secondary drying [18]. On the contrary, 
smaller supercooling (high nucleation temperature) leads to the oppo-
site phenomenon (heterogenous nucleation) and the smaller number of 
larger crystals which shortens the primary drying time and lengthens the 
secondary drying time. In addition, different vials face uneven cooling 
conditions that cause vial-to-vial and batch-to-batch variability in 
practice (for more detailed description, please refer to Pisano et al. 
(2019) [19]). Due to the profound influence on the final product and the 
whole freeze-drying process, freezing is the first critical step that needs 
to be optimized and controlled systematically. 
In freeze-drying, the final product must be elegant cake and 
collapsed cakes are generally disposed of due to their unpreserved 
structure, potentially prolonged reconstitution times, and decreased 
stability [20]. To obtain an elegant cake, one key issue is to prevent the 
collapse of the cake during the freeze-drying process. Collapse 
Fig. 2. The schematic flow-chart of Quality-by-Design ideology. First, critical quality attributes, critical process parameters, and critical material attributes must be 
defined, and their relationships clarified. Second, risk assessment is performed. Third, design of experiment is conducted by scientifically determining the re-
lationships between process factors. Risk assessment and quality target product profile are constantly reflected to each other to optimize the outcome. 
A. Merivaara et al.                                                                                                                                                                                                                             
Journal of Controlled Release 336 (2021) 480–498
483
temperature (Tc) is the temperature in which a sample being freeze- 
dried will collapse and it can be determined experimentally for 
example, by direct microscopic observation or by determining the glass 
transition temperature of maximally freeze-concentrated sample (Tg’) 
by thermal analysis [21]. Determining Tc is more laborious than Tg’ 
and, in general, Tc is 1–2 ◦C higher than Tg’, which means that Tg’ can 
be used as a trustworthy estimation for Tc. 
Since virtually all chemical species are insoluble in ice [22], as the 
formation of the solid ice continues, the amount of free water decreases 
resulting in the increased concentration of any solute present in the 
sample. The freeze-concentration of solutes increases the viscosity of the 
solution until no more solid ice can form. At such point, the sample has 
gone through glass transition and this temperature is called Tg’, the glass 
transition temperature of the maximally freeze-concentrated sample. To 
optimize the freeze-drying process, and to avoid a trial-and-error 
approach, it is necessary to determine the Tc or Tg’ and to monitor 
the temperature of the sample throughout the whole freeze-drying 
process to ensure that the temperature of the sample does not exceed 
Tc. Freeze-drying cycle run at a temperature higher than Tc may lead to 
a collapse of the samples, while lower temperatures will lead to a longer, 
and thus more expensive, cycle. 
In polymers, in particular biopolymers, such as polysaccharides, Tg’ 
is defined by the intersection between the cryoscopic depression curve 
and the composite Tg defined between ice and the solute. [23]. How-
ever, the Tg is an eminently kinetic phenomenon whereas the cryoscopic 
depression is purely thermodynamic. The consequence is that Tg’ will 
depend on the velocity of freezing as shown in Qin et al. 2020 [24]. 
These considerations are coherent with the particularly relevant place 
that the cooling rate has played in domains such as cryobiology. In fact, 
the control over the cooling rate has been instrumental in determining if 
the freezing is accompanied by ice nucleation and growth leading to 
phase separation (slow freezing) or vitrification in which case no phase 
separation is observed (high cooling rates). 
In the last two decades, the emergence of a materials processing 
technique that fully relies on the freezing step as the driving force to 
shape materials – ice templating, also called freeze casting – has led to 
the perception that thermal control over the samples' environment 
provided insufficient control over the local ice nucleation and growth 
[25]. The mechanical performance of materials prepared by ice tem-
plating depends strongly on the inner porosity of the material that is 
generated from the sublimation of ice crystals. Aiming at homogenizing 
the size and spatial distribution of the pores – but also as a manner to 
mimic specific natural materials such as nacre [26–28] – the fabrication 
technique has evolved to integrate spatial control over the freezing 
process. This has been done either by designing freezing setups that can 
exhibit controlled thermal gradients. As a result, control over the ice 
crystal growth led to structures with the preferential alignment of the 
pores along the predefined thermal gradient. 
The equivalent advances took place in the context of cryobiology – 
under the name of directional freezing – where the application of 
controlled linear thermal gradients to freeze biological entities has led to 
some interesting results in cell cryopreservation [29–32]. However, 
beyond the relative success of cryopreservation protocols based on 
directional freezing, controlling the thermal gradient enables to decor-
relate nucleation and growth during freezing, a key step in rationalizing 
freezing. Ishiguro and Rubinsky (1994) [33] pioneered the microscopic 
observation of the interaction between the ice front during freezing and 
red blood cells in suspension opening a pathway to the in-situ obser-
vation of freezing events [24,34,35]. The microscopic observation of 
freezing events has systematically shown that controlling the ice front 
velocity is central to predict the fate of the suspended matter during 
freezing. These results strengthen the importance of separating nucle-
ation from growth during freezing. In fact, in traditional or isotropic 
freezing, where cooling rate is controlled rather than the thermal 
gradient, samples tend to cool down more homogeneously with slight 
local fluctuations, which leads the freezing process to occur mostly 
dictated by the nucleation step, since the whole sample (or at least a 
large volume fraction of the sample) will be supercooled at the moment 
the freezing starts. Such type of freezing event is generally poorly 
controlled in terms of the temperature at which it occurs – homogeneous 
nucleation being a stochastic process dependent on the formation of 
energetically favorable ordered water clusters – and in terms of the local 
velocity of the front. On the contrary, freezing samples based on a 
controlled gradient creates a limited supercooling volume within the 
sample (where nucleation will take place) followed by ice crystal's 
growth in the rest of the sample that is controlled by the thermal 
gradient (Fig. 3). This strategy enables to fix the exact temperature at 
which the ice front will interact with the liquid front and to precisely 
control the ice front velocity. Additionally, since in directional freezing 
growth is favored with respect to nucleation, samples are less exposed to 
heterogeneous nucleation due to the action of suspended matter than in 
isotropic freezing. Although there are presently no commercial freezing 
setups for directional freezing, the different approaches used to apply it 
have been recently described by Qin et al. (2021) [28]. 
Arsiccio and Pisano (2018) used mechanistic Computational Fluid 
Dynamics (CFD) modeling to predict temperature profiles during the 
freezing [36]. From the temperature profile, they were able to calculate 
the freezing front velocity and the temperature gradients within the 
freezing zone. From that data, it is possible to calculate ice crystal sizes 
during freezing. When ice crystal sizes are known the DS of freezing can 
be established in order to get desired primary and secondary drying 
conditions. Later Arsiccio et al. (2020) illustrated how to create DS with 
two model proteins with different denaturation mechanisms during 
freezing [37]. The denaturation mechanism of the first protein was 
driven by the ice-water interface and for the second one, cold denatur-
ation was the main denaturation mechanism. They used mechanistic 
CFD modeling to create the DS for both scenarios. For the first model 
protein, DS aimed to minimize the surface area of the ice-water interface 
with slow cooling. For the second model protein, the DS of the fast 
cooling rate was defined to decrease the duration of freezing. 
QbD ideology can be applied for freeze-drying of biomaterials and 
cells to optimize freeze-drying in general, for example, to shorten the 
freeze-drying cycle. QbD ideology can be also applied specifically for 
biomaterials and cells, by first recognizing CPP and CMA of each step of 
the freeze-drying process. For example, CPPs for the freezing step 
include freezing rate, ice front velocity, and CMA include Tg’ and vis-
cosity. Learning from the freeze-drying of proteins, CFD modeling could 
be utilized to understand the ice front velocity and temperature gradi-
ents and to control the ice crystal sizes. 
2.2. Primary drying: Removing frozen water 
Primary drying is the main step of drying and usually the longest 
phase in the freeze-drying process, thus another critical step of formu-
lation and process optimization. Also in the case of an uncontrolled 
freezing step, primary drying is the source of heterogenous sublimation 
rate which rises a challenge to define DS. During the primary drying 
step, the frozen solid water (ice) is sublimated under a vacuum. The 
driving force of sublimation is the vapor pressure difference (more 
precisely the temperature difference) between the frozen water and the 
surface of the condenser [8]. Sublimation requires heat, which is pro-
vided to the sample through three different ways: 1) radiation, 2) con-
duction, and 3) convection (Fig. 4). The heat provided has to be high 
enough to facilitate sublimation of ice (the latent heat of sublimation of 
frozen ice), but the temperature of the sample must stay below Tg’ to 
prevent collapsing of the freeze-drying cake. It is important to keep the 
chamber pressure under the saturation vapor pressure of ice during the 
whole process to facilitate the sublimation of ice. Lower pressure in-
creases the vapor pressure difference between the condenser and ice but 
decreases remarkably heat flow through convection, which slows down 
the sublimation. 
Van Bockstala et al. (2018) studied following Good Modeling 
A. Merivaara et al.                                                                                                                                                                                                                             
Journal of Controlled Release 336 (2021) 480–498
484
Practice the most important process parameters during primary drying 
[38]. They used Global Sensitivity Analysis (GSA) to take into account 
uncertainty process parameters. They used both a regression-based and 
variance-based GSA in their mechanical CFD model input parameters on 
the output parameters of sublimation rate and the temperature at the 
sublimation front. Models were validated with DoE. They concluded that 
the mechanical CFD model together with GSA were in good agreement 
with experimental DoE validation studies. The advantage of this kind of 
approach is that uncertainty can be taken into account in models and 
consequently the Risk of Failure, for example, cake collapse, can be 
calculated. Another advantage of mechanistic modeling with uncer-
tainty estimation is that since freeze-drying is a transient process, dy-
namic DS can be established. Earlier Mortier et al. (2016) has used the 
same approach and they highlighted that the Risk of Failure acceptance 
level 0.01% yielded zero defects in the quality of end-product [39]. 
Shelf temperature and chamber pressure can be recognized as CPP 
and vial geometry fill depth as CMA when applying QbD for the primary 
step of freeze-drying. In addition, as described in the previous chapter, 
valuable information can be obtained by GSA also when freeze-drying 
biomaterials and cells. Furthermore, with correct risk assessment, the 
risk of collapse of biomaterials and cells during primary drying, can be 
reduced. 
2.3. Secondary drying and storage: Removing unfrozen water and storing 
vials 
Typically, secondary drying aims to remove any unfrozen water still 
present in the sample (Fig. 5) [18]. Although water is usually present as 
a hydrate in crystalline hydrate or an amorphous solid, the amount of 
unfrozen water can still be remarkable (20–50%) particularly for some 
Fig. 3. The boundary conditions applied during 
isotropic or directional freezing determine the local 
thermal gradient and the distribution of local ice 
front velocities. A) Schematic representation of the 
local thermal gradient developed during isotropic 
and directional freezing. The purple to salmon back-
ground indicates the thermal gradient and the red 
arrows depict the direction and local ice front ve-
locity. B) Simplified representation of the ice front 
velocity distribution depending on the type of 
freezing conditions. Examples of critical process pa-
rameters and material attributes in the freezing step 
are listed right. (For interpretation of the references 
to colour in this figure legend, the reader is referred 
to the web version of this article.)   
Fig. 4. The heat flow (red arrows), mass transfer 
(blue arrows), and factors affecting the time required 
for sublimation (bullet points) during primary drying. 
Heat-flow by convection and conduction vary 
depending on the pressure in the freeze-drying 
chamber and geometry of the freeze-drying vial, 
respectively. Examples of critical process parameters 
and material attributes in the primary drying step are 
listed right. Qin = Energy supplied for sample. Kv =
heat transfer coefficient from shelf to the sample. 
Tshelf = Shelf temperature. Tproduct = product tem-
perature. Qout = Energy required to sublimate water. 
Hs = latent heat of sublimation. dm / dt = mass 
transfer of ice over time. Modified from Franks 2008 
[8] and Pikal et al. 1984 [9]. (For interpretation of 
the references to colour in this figure legend, the 
reader is referred to the web version of this article.)   
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amorphous formulations [8]. Secondary drying can be performed at 
elevated temperatures because the ice has been removed during the 
primary drying and the risk of melting or collapsing is minimal. How-
ever, especially with the amorphous materials, temperature elevation is 
preferably performed with a slow ramp (≤ 1 ◦C/min) to avoid 
collapsing. The residual water contents of samples after secondary 
drying are generally recommended to be 0.5–3% [8], however, some 
biological samples require higher residual water contents to be recon-
stitutable [40]. The role of residual water is discussed more in chapter 5. 
The secondary drying is also a critical step to optimize due to practical 
influence on the final product. As an example of the process optimiza-
tion in secondary drying, Assegehegn (2020) created the DS for optimal 
residual water content (1.3–1.8% (w/w)) and the Tg (+60–68 ◦C) of dry 
end product using DoE [41]. Their input variables were secondary 
drying temperature and time, and vacuum setting. They concluded that 
a high vacuum setting (0.05 mbar) increases the desorption rate of 
water. Despite the improved heat transfer with a lower vacuum (higher 
chamber pressure), the desorption rate is lower, due to increased vapor 
flow through the pore structure which decreases the drying rate signif-
icantly. The most optimal secondary drying temperature and time were 
+ 37 ◦C and 12 h, respectively. Verification run with these settings 
confirmed that desired output values were achieved. Optimal residual 
water content is extremely important to successfully reconstitute freeze- 
dried biomaterials and cells and creating a DS for optimal residual water 
content would be useful. In secondary drying, the rate of temperature 
elevation and vacuum settings can be recognized as CPP and residual 
water content as CMA. 
Finally, after secondary drying, the vials are closed in the desired 
atmosphere which is usually dry nitrogen. Storage temperature for the 
freeze-dried samples should be below their glass transition temperature 
(Tg) where their stability is higher due to lower mobility and no 
collapsing occurs [42]. For economical and practical reasons, product 
storage at room temperature can be considered one of the driving rea-
sons to freeze-dry material. During storage, the moisture and tempera-
ture of the surroundings and atmosphere in the vial can be considered as 
CPP, while residual water content and followed by that Tg of the dry 
sample, can be recognized as CMA. 
3. Changes in chemical, physical and mechanical environments 
during freeze-drying 
Freezing of water, and sublimation of ice are the most important 
phase transitions of water during freeze-drying. They affect the chemi-
cal, physical, and mechanical environments of the biomaterials and 
cells. Changes in the previously mentioned environments can be fatal 
unless addressed by choosing for example the correct excipients, 
freezing method, and freeze-drying cycle. In this chapter we discuss and 
review the chemical, physical, and mechanical environments around the 
cells and biomaterials during the freeze-drying and how to prevent the 
damage caused by changes in the environments. 
3.1. Chemical environment 
The chemical environment is composed of the excipients and sol-
vents used in the freeze-drying process. In addition to protective and 
bulk-forming agents, excipients are required to control the physico-
chemical properties of the formulations such as pH, osmolarity, and 
ionic strength, with buffers and tonicity modifiers. Furthermore, the 
biomaterials and cells themselves affect the chemical environment. 
During the freezing step of freeze-drying, the concentrations of sol-
utes increase as the volume of the solvent decreases (Fig. 6). This results 
in chemical gradients between the cells or biomaterials and their 
external solution. In the common case where the solvent is water, its 
activity will alternate throughout the freezing and drying steps, result-
ing in a chemical environment with extremely limited water activity. In 
addition, the transition of the solvent molecules from the liquid to the 
solid phase may promote solute concentration and subsequent precipi-
tation caused by reaching its solubility limit [43]. However, the pre-
cipitation during the process happens seldom and it can be easily 
avoided by choosing the correct excipients. The freeze concentration 
may affect the pH, in particular, if buffer components precipitate [43]. 
However, as with other solutes, this phase separation during freeze 
concentration is rare. Other concerns related to the shifts in pH rise from 
choosing a volatile buffer. If the chosen buffer, such as acetic acid, is 
volatile and the buffer sublimates during the primary drying, changes in 
the pH of the sample will be observed after reconstitution. 
Freeze-drying affects the chemical bonds, such as hydrogen bonds, 
between the active ingredient, solute, and solvents. Removing the water 
and thus the hydrogen bonds water has formed with the biomaterial or 
cells, can result in not reconstitutable samples if not addressed by 
excipients. 
3.2. Physical environment 
By physical environment, we describe the physical parameters which 
change during freeze-drying. Such parameters are thermal gradients, 
osmotic pressure, and pressure caused by the ice during freezing (Fig. 6). 
Especially cells and cell-derived biomaterials, such as extracellular 
Fig. 5. A) During secondary drying the non-frozen 
water of the sample is removed with elevated tem-
perature in a freeze-drying chamber. The residual 
water content of biomaterials and cells must be 
optimized because the driest possible sample is not 
always the best. Critical process parameters and 
critical material attributes in the secondary drying 
step are listed below. B) The aim of freeze-drying is to 
obtain an elegant freeze-drying cake that can be 
preferably stored at room temperature and which is 
rapid to reconstitute. Critical process parameters and 
critical material attributes in the storage step are 
listed below.   
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vesicles (EVs), require isotonic conditions. Due to osmosis, the water 
will flow out of cells, if the extracellular environment is hypertonic and 
the cells will shrink. Conversely, if the extracellular environment is 
hypotonic, the water will flow inside the cells and the cells will swell. 
During freeze-drying, especially in the freezing step, there will be drastic 
changes in osmotic pressure that can damage the cells and induce 
denaturation of proteins [43]. Even within the slow freezing domain, 
different cooling rates promote different osmotic imbalances leading to 
the characteristic bell-shaped curves of cell viability vs. cooling rate 
[44]. 
Thermal gradients will occur during the freezing step and drying step 
[8,9]. Thermal gradients can cause challenges in controlling the tem-
perature which can result in cryodamage for the biomaterials and cells. 
Furthermore, strong thermal gradients can lead to collapsing of the 
sample if the collapsing temperature is exceeded. 
Pressure induces apoptosis and necrosis at 200 MPa and 300 MPa in 
mammalian cells, respectively [45]. Avoiding pressure-induced 
apoptosis and necrosis can improve the recovery of cells after freeze- 
drying and reconstitution. Controlling the ice front velocity is one way 
to maintain the pressure caused by ice nucleates below the critical 
pressure [35]. Controlling the geometry of the thermal gradient applied 
can also help to address problems related to the forces exerted during 
freezing. 
3.3. Mechanical environment 
Mechanical properties, such as the stiffness of the material can 
change during freeze-drying (Fig. 6). These changes determine the final 
form and elastic properties of the freeze-dried biomaterials. When cells 
are present, these changes may be dramatic since the biological response 
of cells may be directly linked to the surrounding mechanics [46–48]. 
Changes in the mechanical environment may impair the growth of cells 
– therefore proper formulating and control over the freezing and drying 
steps are important to counter changes in the mechanical properties of 
the freeze-dried samples. 
To summarize, we believe that the preservation of complicated 
natural biomaterials and cells by freeze-drying requires a wide under-
standing of the chemical, physical, and mechanical environments sur-
rounding the subject of interest. It is vital to not only adjust each 
environment individually but to consider how changes in one affect all 
of them. Until now, the trial and error approach is prevalent, but we 
suggest that more careful design and consideration are fundamental to 
succeed in the freeze-drying of biomaterials and cells with even better 
results. 
3.4. Role of excipients in different environments 
Saccharides, polysaccharides, proteins, and alcohols have different 
properties that might pave the way for success in freeze-drying 
(Table 1). The excipients can be categorized as stabilizers and bulking 
agents and act mainly as kinetic stabilizers or as thermodynamic stabi-
lizers [49]. The idea of kinetic stabilization also referred to as the glass 
dynamic hypothesis, explains that excipients form a highly viscous 
amorphous matrix that reduces the rate of degradation reactions. 
Thermodynamic stabilization also referred to as the water replacement 
hypothesis, states that excipients form hydrogen bonds that replace the 
hydrogen bonds water had with the samples. However, neither of these 
theories alone fully explains, how excipients protect samples, which 
underlines the importance of considering both theories in the freeze- 
drying process. 
Trehalose is the most common excipient in the freeze-drying of 
biomaterials and cells, and it can be used as a bulking agent and as a 
stabilizer in freeze-drying systems. Trehalose (MW = 378.33 g/mol, 
dihydrate) is a non-reducing disaccharide formed by two glucose units 
that are linked together by α-(1 1)-linkage. Tg’ of trehalose and water 
solution is − 28 ◦C [8], and Tg of pure, dry, amorphous trehalose varies 
between 75 and 120 ◦C [50]. Variation is observed probably due to 
different residual moisture contents in trehalose. Trehalose is more 
commonly found as dihydrate than anhydrate. Trehalose is highly hy-
drophilic (Log P -3.77, T = 20 ◦C) [51], which can make the use of 
trehalose as a stabilizer for cells challenging. 
Trehalose forms a highly viscous matrix during freeze-drying and 
provides hydrogen bonds to substances being freeze-dried. Trehalose is 
used by organisms that can tolerate desiccation [52]. Contrary to 
reducing sugars, such as lactose and glucose, non-reducing sugars do not 
react through the Maillard reaction (browning reaction) with basic 
amino acids of proteins which makes non-reducing saccharides more 
attractive for freeze-drying processes [49]. However, the potential of the 
Maillard reaction does not prevent the usage of reducing sugars as 
excipients. 
Fig. 6. Changes in chemical, physical, and mechan-
ical environments around the biomaterials and cells 
during freeze-drying. Changes in the chemical envi-
ronment are related to concentration changes during 
freezing and drying. The solute concentration in-
creases during freezing when the amount of liquid 
water decreases. This affects also pH and hydrogen 
bonds formed with the biomaterial or cells and water. 
In the physical environment osmotic pressure in-
creases during freezing and there will be thermal 
gradients during the whole freeze-drying cycle. The 
mechanical environment describes how the mechan-
ical properties of biomaterials and their exterior 
change during freeze-drying. Changes in the me-
chanical environment are hard to analyze during the 
freezing and drying, but the arrows indicate that the 
mechanical properties can vary in any direction after 
freeze-drying if the freeze-drying and reconstitution 
were unsuccessful. These changes can have dramatic 
results in the applicability of the biomaterials or the 
survival of the cells.   
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Biopolymers act in general as bulking agents in the freeze-drying 
process. Biopolymers may also have a positive impact on the critical 
temperatures, mainly Tg’ and Tg, of the freeze-drying formulations 
making their usage justifiable. 
Human serum albumin (HSA) and bovine serum albumin (BSA) are 
proteins, and they are widely used excipients in the freeze-drying of 
cells. Albumin of either origin is commonly present also in the cryo-
preservation media of cells, as media is supplemented generally with 
fetal bovine serum or human serum. Considering the freeze-drying, al-
bumin increases the Tg of dry samples which makes the storage of 
freeze-dried biomaterial samples or cells feasible at room temperature 
[64]. However, the protective mechanism of albumin is still unclear. 
Mannitol is a sugar alcohol that is widely used as a bulking agent in 
freeze-drying formulations. It crystallizes during the freeze-drying pro-
cess and provides mechanical strength and improves the elegancy of the 
freeze-drying cake. 
Dextran is a branched polysaccharide formed from glucose mono-
mers. Dextran is a commonly used excipient in the freeze-drying of small 
molecules as a bulking agent and as Tg’ modifier because it has a rela-
tively high Tg’, − 10 ◦C [54]. Dextran has been also studied in the freeze- 
drying formulation and a rehydration solution with cells [65,66]. 
Glycerol is a polyol and commonly used cryoprotective agent which 
prevents the formation of harmful ice crystals. Glycerol might prove 
useful especially in the freeze-drying of the cells. However, glycerol 
decreases Tg’ especially with high concentrations hindering its usability 
in freeze-drying. 
DMSO is a sulfoxide and the most commonly used cryoprotectant 
with the cells. DMSO prevents intracellular and extracellular ice crystal 
formation and protects the cells from the damage caused by freezing. 
However, DMSO decreases Tg’ and causes similar problems in freeze- 
drying as glycerol [63]. In addition, DMSO is toxic to cells that cause 
problems in clinical applications, and requires washing of the cells after 
preservation. 
Polyvinylpyrrolidone (PVP) has been used in the freeze-drying of red 
blood cells as an excipient [67]. PVP decreased the formation of ice 
crystals and increased the extent of vitrification during freezing. How-
ever, high PVP concentration damaged the cells probably due to high 
osmotic pressure and decreased the recovery of intact red blood cells. 
Polyethylene glycol (PEG) can prevent the damage caused by ice crystals 
and improve the uptake of water in the reconstitution after freeze- 
drying. However, with EVs PEG caused aggregation potentially due to 
interactions with the EVs [68]. 
Nanofibrillated cellulose is a biomaterial produced from the nature 
origin polysaccharide cellulose which is formed from glucose mono-
mers. The fibers of nanofibrillated cellulose have a high length to width 
ratio: width is on the nanometer scale and length in the micrometer 
scale. Nanofibrillated cellulose forms highly viscous hydrogels with 
water and it has a wide range of applications in the biomedical field. 
This biomaterial can be used for example for 3D cell culturing [69]. We 
studied the potential of nanofibrillated cellulose as an excipient in the 
freeze-drying of 3D cultured cells and showed that nanofibrillated cel-
lulose provides mechanical strength and acts as a bulking agent in the 
freeze-drying process and during storage [70]. In addition, nano-
fibrillated cellulose acts as hygroscopic material [71] which improved 
the uptake of water at the reconstitution phase. 
4. Analysis of freeze-drying process and environments with 
biomaterials and cells 
In the previous chapter, we have introduced the concept of different 
environments and changes in them during freeze-drying. However, 
recognizing these environments is not enough, but also understanding 
how to analyze them, is important. We have divided the analysis of the 
whole freeze-drying process into three major steps: 1) designing 
formulation, 2) optimizing the freeze-drying cycle, and 3) evaluating 
product during storage. 
Traditionally, the formulation, freeze-drying cycle, and preservation 
of the sample have been studied offline before and after the freeze- 
drying process. We suggest that the utilization of process analytical 
technology (PAT) is required in order to freeze-dry the biomaterials and 
cells with a higher yield. PAT is defined by European Medicine Agency 
[72] and the Food and Drug Administration [73] as a system for designing 
and controlling manufacturing through timely measurements (i.e. during 
processing) of critical quality and performance attributes for raw and in- 
process materials and also processes with the goal of ensuring final product 
quality. Recently, vibrational spectroscopic techniques as Raman and 
infrared (IR) spectroscopies have gained interest as PAT tools to char-
acterize the freeze-drying product and freeze-drying cycle. Vibrational 
spectroscopic techniques are non-invasive, widely applicable, low-cost, 
quick time-to-result analytical methods. Although vibrational spectro-
scopic techniques provide a set of powerful tools to describe samples 
during the freeze-drying cycle, they are often limited to an average 
image with poor local resolution. This is one reason why in situ analyses 
are as well performed to obtain comprehensive information on the 
freeze-drying process. The most important methods and instruments 
that are potential for characterizing different environments at different 
Table 1 
Summary of the number of the publications found so far and the chemical properties of the natural origin excipients used in the freeze-drying of extracellular vesicles 
(EVs) and cells. For a comprehensive list of excipients used in the freeze-drying of proteins and small molecules, please refer to Gervasi et al. (2018) and Baheti et al. 
(2015) [53,54]. Data obtained from PubChem, FooDB, and polymerdatabase unless otherwise stated.  
Excipient N:o of art Group MW HBD HBA PSA pKa LogP Tg’ (water solution) Tg 
Trehalose dihydrate 17 Disaccharide 378.3 10 13 192 11.91 -3.77 − 28 [8] 75–120 [50] 
HSA, BSA 5 Protein ~66 kDa    / / / / 
Mannitol 3 Sugar alcohol 182.2 6 6 121 13.5 − 3.1 / 13 [55] 
Sucrose 3 Disaccharide 342.3 8 11 190 12.6 − 3.7 − 32 [8] 52–76 [50] 
Glycerol 2 Alcohol 92.1 3 3 60.7 14.4 − 1.76 − 109.6 [56] − 93 [57] 
Dextran 2 Polysaccharide >1000 da 11 16 277 11.78 − 3.30 − 10 [54] 61.7–101.7 [58] 
Sodium Alginate 1 Polysaccharide 216.1 (monomer) 4 7 130 3.21 − 1.9 − 80 [59] / 
EGCG 1 Polyphenol 458.4 8 11 197 7.99 2.38 / 163 [60] 
Glucose 1 Monosaccharide 180.2 5 6 110 12 − 3.1 / 21.9 [61] 
Lactose 1 Disaccharide 342.3 8 11 190 11.25 − 3 / 84 
Maltose 1 Disaccharide 342.3 8 11 190 11.25 − 3 − 31 [62] / 
NFC 1 Polysaccharide 162.1 (monomer) / / / / / / / 
HES 1 Polysaccharide 580.6 (monomer) 17 17 267 / / / / 
PVP 1 Polyetherketone 111.4 (monomer) 0 1 20.3 / / / 169.9 
DMSO 1 Sulfoxide 78.14 0 2 36.3 35.1. − 1.35 − 120 [63] / 
PEG 1 Polyglycol 44.05 (monomer) 2 2 40.5 15.1 − 1.36 /  
MW: Molecular weight; HBD: Hydrogen bond donors; HBA: hydrogen bond acceptors; PSA: Polar surface area; HSA: Human serum albumin; BSA: Bovine serum 
albumin; EGCG: Epigallocatechin gxallate; NFC: Nanofibrillated cellulose; HES: Hydroxyethyl starch; PVP: Polyvinylpyrrolidone; DMSO: Dimethyl sulfoxide; PEG: 
Polyethylene glycol 
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steps are summarized in Fig. 7. 
4.1. Analysis of the formulation before freeze-drying 
The formulation should protect the biomaterials and cells from the 
harmful changes in the different environments during freeze-drying. 
Adjusting the formulation to be suitable for the biomaterials and cells 
and choosing the excipients to protect them during the freeze-drying and 
storage, are the most important steps in the formulation phase. 
Even though sounding self-evident, basic characterization of the 
formulation is important. For the biomaterials and cells, measuring the 
osmolality of the formulation with an osmometer, such as freezing point 
depression osmometer, and pH with the pH meter are extremely 
important. The mechanical properties of the formulation, such as stiff-
ness and elasticity, can be determined with a rheometer and optimized 
for the desired application. In the formulation phase, sample-specific 
reference measurements, such as the viability of cells or the viscosity 
of hydrogel, are recommended. Then after freeze-drying and reconsti-
tution, the success of the freeze-drying process can be evaluated by 
comparing the results to the unprocessed sample. 
The formulation affects not only the biomaterials or cells but also 
design of the freeze-drying cycle. In other words, the formulation can be 
optimized to be suitable for the freeze-drying cycle for example by 
adjusting excipients to increase Tg’. Commonly, designing the freeze- 
drying cycle includes the utilization of characterization instruments to 
analyze temperatures necessary for the process [74]. Differential scan-
ning calorimetry (DSC) and freeze-drying microscope (FDM) can be used 
to analyze important phase transition temperatures of the sample before 
freeze-drying [75]. DSC is used to analyze changes in the crystal struc-
ture, eutectic formation, and amorphous characters of the formulation 
[74,76]. FDM consists of a microscope attached to a freeze-drying 
chamber and it is designed to analyze important phase transition tem-
peratures for freeze-drying [77,78]. The advantage of FDM is the pos-
sibility to detect a specific collapse temperature of the formulation and 
to evaluate in real-time the sublimation rate of the ice. In addition, the 
effects of crystallization and annealing on the formulation can be 
recorded. 
4.2. Analysis of biomaterials and cells during the freeze-drying cycle and 
its steps 
After starting the freeze-drying cycle, the temperature of shelves in 
the freeze-drying chamber, condenser temperature and sample tem-
perature must be recorded. In addition, following the pressure inside the 
Fig. 7. Characterization methods suitable for detecting changes in the chemical, physical, and mechanical environments during different phases of the freeze-drying 
process. First, analyzing properties of the formulation categorized into different environments and optimizing the formulation. Second, detecting changes in the 
environments during the freeze-drying cycle and optimizing the freeze-drying cycle. Third, observing changes in the environments during storage. 
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freeze-drying chamber and condenser is required. Nail et al. (2017) have 
presented recommended best practices for process monitoring instru-
mentation in pharmaceutical freeze-drying and they introduce common 
methods to follow the temperatures and pressures during the freeze- 
drying cycle with different thermometers and manometers, respec-
tively [79]. However, in this review, in situ methods and biophotonic 
label-free detection methods are introduced to gain more detailed in-
sights about the freezing step and how to study the samples during the 
freeze-drying cycle. 
4.2.1. In situ analysis of freezing step 
In situ analysis of the freezing process elaborates in detail, how the 
samples are locally influenced during freezing. In this context, locally 
means it is possible to discriminate between ice-rich zones and zones 
formed in between the ice crystals. 
The challenge in characterizing the samples locally during freezing is 
that it requires a particularly controlled freezing process. Ishiguro and 
Rubinsky have addressed this problem using a directional freezing setup 
[33]. In their report, they investigated the mechanical interactions 
developed during freezing red blood cells by placing a glass slide con-
taining a cell suspension over a controlled thermal gradient. Pushing the 
glass slide over the thermal gradient enabled to visualize the growth of 
ice crystals and their interaction with the suspended cells. While it was 
impossible to withdraw quantitative data from the local analysis, the 
observation of microscopy images allowed to establish the initial rela-
tionship between the ice front velocity and the fate of cells after freezing. 
In particular, the distribution of cells between the interstitial zones i.e. in 
between ice crystals and trapped within ice crystals seemed particularly 
sensitive to the ice front velocity. This approach was recently extended 
to probe the interaction of suspended droplets and particles with a 
moving freezing front [34,80]. By coupling a confocal microscope to a 
controlled temperature gradient, the authors were able to describe the 
interaction of the suspended particles with the moving ice front as well 
as the compaction occurring laterally by the ice crystals over the 
segregated zones. The same setup was later applied to study the inter-
action between living yeast cells and the moving ice front on alginate 
solution. The image analysis of the segregated zones, coupled with 
calorimetric data, allowed to describe the evolution of the solute con-
centration along the ice growing direction, establishing experimentally 
the local concentration evolution endured by cells during freezing [24]. 
As with previous reports within this section, this work highlighted the 
primordial role of ice front velocity in the cells' local environment and 
survival. Interestingly, a relatively modest change in ice front velocity 
from 10 to 50 μm s− 1 resulted in a drop in local alginate concentration in 
between ice crystals from 40 to 20 wt%. While these changes in ice front 
velocity did not change the distribution of cells between the interstitial 
space and ice crystals it dramatically impacted cell viability. 
A more fundamental take on the local environment produced during 
freezing has been unveiled using time-resolved Small Angle X-Ray 
Scattering on synchrotrons. By studying the self-assembly of amphi-
philic molecules in the liquid phase during freezing, Albouy and col-
leagues were able to describe the self-assembly changes occurring below 
0 ◦C [81]. Starting with a P123 copolymer in solution – in between the 
beam and the detector – and upon application of a thermal gradient, the 
authors could show that the concentration variation imposed by the 
freezing front determined an evolution of amphiphilic molecules from a 
diluted, disordered state to form, consecutively micelles, an hcp phase of 
micellar aggregates, and reaching eventually a 2D-hexagonal phase of 
cylindrical micelles. Although P123 molecules are not strictly compa-
rable to the molecules that define many of the biological membranes 
such as phospholipids, the ability to modulate the arrangement of sys-
tems directed by weak interactions during freezing, raises important 
questions on the stability of biological structures such as lipid vesicles 
during freezing. Recently, Baccile et al. have reported the study of lipid 
lamellar phases during ice templating using a comparable freezing 
setup. The particularity of the chosen lipid phase consisted of large 
changes in a lamellar period that varied with the local pressure in be-
tween the lipid lamellae [35]. Measuring the variations in the lamellar 
period provided instrumental in quantifying the internal pressure 
formed in between ice crystals during freezing. Their results describe, 
for the first time, the remarkably high-pressure values (between 1.5 and 
3 kbar) endured during freezing in absence of standard cryoprotection 
agents. 
Despite their fundamental nature, and as a consequence, despite 
their distance to the actual freeze-drying conditions, these results pro-
vide much-needed guidelines to understand the multiple phenomena 
occurring during freezing. The results are especially relevant when it 
comes to systems whose integrity depends on weak interactions as with 
many biologicals. It is worth pointing out that in all cases, the strict 
definition of a thermal gradient is necessary to ensure the whole freezing 
process is dully observed. An extension of these principles to the whole 
freeze-drying process would certainly clarify many of the underlying 
modifications occurring throughout the multi-step process and establish 
full complementarity with the PAT analysis. 
4.2.2. Raman and near-infrared spectroscopies in monitoring of freeze- 
drying cycle 
In recent years, Raman and near-infrared (NIR) spectroscopies have 
been applied in-line in freeze-drying gaining profitable information 
[82,83] for the characterization and the monitoring of freeze-drying of 
protein, liposomes, active pharmaceutical ingredients (API), and ex-
cipients (Fig. 8). Both techniques display unique advantages; both are 
label-free, fast, non-destructive, and operator-independent. 
Raman spectroscopy is based on Raman scattering, a 2-photon pro-
cess, where a photon emitted by a source of monochromatic light in-
teracts with the sample. This interaction increases the virtual energy 
state for a short period before the second photon with either lower or 
higher energy is emitted. Raman spectroscopy has been successfully 
applied as an in-line PAT tool to monitor the starting of ice nucleation 
and product crystallization, freezing and primary drying endpoint, and 
the evolution of the product solid state during the entire process. The 
second derivative of the amide III (1200–1380 cm-1) region of the 
Raman spectra can underline how the water content affects the freeze- 
drying cycle as well as the stability of protein and, potentially it can 
be used as a tool for long term stability studies [84]. 
Infrared spectroscopy is based on the interaction of infrared radia-
tion with matter, where the frequency of the radiation absorbed by the 
molecules matches the vibrational frequency. Near-infrared (NIR) signal 
(10,000–4000 cm-1) originates from the excitations of higher quanta 
transitions, mostly first overtones and binary combinations. 
NIR spectroscopy reveals little chemical composition information, 
but it is sensitive to a multitude of compounds and molecular in-
teractions. NIR spectroscopy outperforms Raman spectroscopy when it 
comes to the monitoring of the drying process and is preferred in 
monitoring the drying process and H-bond formation [85]. NIR spec-
troscopy is especially useful when monitoring the water contents in the 
samples and it can be used to quantify the residual water content. 
Overall, in-line Raman spectroscopy appears to be superior to NIR 
spectroscopy regarding the detection of endpoint of water to ice con-
version, the physical state, and the onset of API and excipients crystal-
lization. However, it appears obvious that NIR and Raman 
spectroscopies are complementary techniques and the simultaneous use 
of both techniques during the monitoring of freeze-drying is the best 
solution for the process control. 
It is worth noting that besides the above-described advantages, NIR 
and Raman spectroscopies have some limitations. Firstly, freeze-drying 
is a stochastic process. Inhomogeneity on the temperature of vials and, 
thus, ice nucleation has been observed. Therefore, controlling the pro-
cess by data obtained from only one vial can be misleading [85]. Sec-
ondly, NIR and Raman spectroscopies can interfere with each other if 
placed on the same vial, especially during the primary drying where the 
frozen product reflects the NIR radiation that can interfere with Raman 
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scattering and its detection resulting in a saturation of Raman spectra 
[83]. Thirdly, information obtained from NIR and Raman spectroscopies 
is affected by where the light source is focused. This can result for 
example in late detection of ice sublimation if the focus is on the bottom 
of the vial. Moreover, IR beam illuminates in most cases a large part of 
the vial, which can explain why it is difficult to discriminate product 
crystallization and the end of the water to ice conversion, while Raman 
spectroscopy, with a smaller focal point, detects events on a specific 
area. Furthermore, the NIR beam can penetrate through the samples 
gathering information on the inner composition. 
The above-mentioned issues can be partially overcome by a careful 
experimental design. Nowadays, a multichannel NIR spectrometer al-
lows the operator to obtain information simultaneously by different 
vials [86,87]. Multichannel Raman spectrometers have been also 
developed although they have not been used in freeze-drying yet [88]. 
4.3. Analysis of freeze-dried biomaterials and cells during storage 
After the freeze-drying cycle, the obtained product must be charac-
terized to ensure successful freeze-drying. In addition, monitoring the 
products during the storage periods, preferably with non-invasive 
methods, can be profitable. 
Successful freeze-drying is ensured by measuring the residual water 
content of the sample with for example thermogravimetry, Karl Fischer 
titration, or gravimetric scaling based on loss on drying. Residual water 
plays a major role in the freeze-drying of biomaterials and cells and the 
standard guidelines of approximately 0.5–3% of residual water may not 
be valid [40]. Monitoring residual water content after freeze-drying and 
during storage can be also performed with NIR spectroscopy [86]. 
Gravimetric scaling and NIR spectroscopy can be performed without 
destroying the sample. However, Karl Fischer titration or thermog-
ravimetry can be more precise methods and they can be used for 
example for calibration and validation of NIR spectroscopy [86]. 
In the future, applying a mathematic model to predict residual water 
contents from the obtained data, would be highly beneficial to improve 
the success of freeze-drying of biomaterials and cells. Before we can 
apply the prediction to the actual process, we have to understand 1) the 
optimal residual water concentration and 2) where the water is precisely 
located i.e. is the water bound water of the membranes and proteins or 
bulk water in the protective matrix. Before setting up a mathematical 
model, in-line residual water content monitoring with NIR provides 
valuable information [86]. 
Another important characterization method for freeze-dried bio-
materials and cells after freeze-drying is scanning electron microscopy 
(SEM) [89]. SEM can be utilized to evaluate the morphology and surface 
structure of the freeze-dried samples. However, SEM is an invasive 
method, and the samples are destroyed after the characterization. 
Vibrational spectroscopy techniques can be applied to optimizing the 
long-term storage conditions of the freeze-dried samples. Raman spec-
troscopy can be applied to evaluate the secondary structure of proteins, 
H-bonding, and the physical status of the samples during storage. With 
NIR spectroscopy information about the physical status and water ab-
sorption are obtained. In addition to the NIR, Fourier-transform infrared 
spectroscopy is utilized to detect water absorption and protein structure. 
Taken together, traditionally utilized devices, such as DSC and FDM, 
and tools to follow the freeze-drying cycle, such as manometers and 
thermometers, are fundamental. However, combining the already 
proven equipment with advanced biophotonic tools and in situ analysis 
of biomaterials and cells, is necessary. 
5. State of the art in freeze-drying of biomaterials and cells 
The relevance of biomaterials in tissue engineering, drug delivery 
devices, or as cell culture platforms for toxicology studies along with the 
Fig. 8. Raman and NIR/FTIR spectroscopies can be applied in-line as possible process analysis technologies (PAT) in the freeze-drying process. Numbers correspond 
to different steps in the freeze-drying cycle. 
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present increase in cell therapies has sparked a need for newer, more 
robust ways to shape, preserve and vectorize these material-cell- 
assemblies [90,91]. One particularly attractive system is the one con-
taining extracellular vesicles (EVs). EVs have recently gained a lot of 
attention as they have potential applications as drug carriers even across 
the blood-brain barrier, as biomarkers, or as therapeutics themselves 
[92–94]. However, there are still obstacles to overcome, such as storage 
and transportation, especially considering the natural biomaterials, such 
as EVs, and cells. In this chapter, we review biomaterial scaffold fabri-
cation by freeze-drying and preservation of EVs and cells by freeze- 
drying. 
5.1. Non-living scaffold materials 
Macroporous biomaterials elaborated via freeze-drying of bio-
polymers have gained considerable attention in surgical procedures for 
their role as hemostats [95] and bone defect fillers [96]. An important 
number of these materials is nowadays commercially available and 
validated by different national and international drug agencies [97]. 
Also, hybrid formulations, that combine biopolymers and hydroxyapa-
tite (and other inorganic moieties) have been freeze-dried to obtain 
macro-porous composite materials relevant in the context of bone 
replacement [98–101]. Despite their satisfactory biocompatibility 
properties, little control over the porosity of the material i.e. pore size 
distribution, orientation, etc., was evidenced. The need for further 
textural control in freeze-dried biopolymers was realized by reports 
suggesting that the morphology of pores could be a determinant factor in 
tissue growth [102]. The integration of ice templating, formerly 
described for the fabrication of lightweight ceramics, in the elaboration 
of biomimetic materials [103] and biomaterials [27,104,105] opened a 
pathway to further increase the control over the texture of macro-porous 
biomaterials [25]. The aligned porosity enabled effective liquid trans-
port properties [106] when compared to randomly oriented porosity 
developed by isotropic freezing [107,108]. These materials favor cell 
colonization [109] nutrients exchange, and, importantly, due to facili-
tated gas diffusion, they provide simple platforms to overcome the ox-
ygen diffusion limitations that hinder extensive cell colonization in 
hydrogels. The list of ice-templated biopolymers used for 3D cell culture 
is vast, ranging from type I collagen [110] to gelatin [111,112] and 
numerous polysaccharides [113,114]. 
Beyond the specific biological response to biopolymer hemostatic 
foams, bone filling materials, or 3D cell culture systems, freeze-dried 
and ice-templated foams display particularly efficient mechanical 
behavior, making them particularly suitable for applications where 
lightweight yet robust behavior is required [115]. Changing the chem-
ical, physical, and mechanical environments before freeze-drying results 
in different scaffolds (Fig. 9). 
5.2. Freeze-drying extracellular vesicles improves their clinical usability 
EVs are nano-sized (< 1000 nm) biological vesicles that are produced 
by all cells according to current understanding [116]. They participate 
in a myriad of actions in normal physiological or pathological events 
[117]. The use of EVs in diagnostics and as drug delivery vehicles are 
currently highly appreciated research topics [118–120]. EVs could be 
used as carriers for targeted drug delivery of small drugs, RNA, and vi-
ruses [121–123]. Liposomes are the closest artificial nanoparticles to 
EVs and their successful freeze-drying remains a topic of interest in the 
pharmaceutical field. Freeze-drying can be utilized to preserve lipo-
somes in dry form at room temperature or to formulate them for 
different administration routes. Freeze-drying of liposomes has been 
recently reviewed by Franzé et al. (2018) [124] and earlier by Chen et al. 
(2010) [125]. In this review, we focus on the freeze-drying of EVs. 
The effect of freeze-drying on EVs is commonly studied by comparing 
various parameters to fresh EVs or EVs stored at − 80 ◦C, which is the 
standard way to store them (Table 2). The number of EVs, their size 
distribution, and morphology are the most common descriptors to 
characterize the success of freeze-drying [68,126–129]. In addition to 
those, the functionality of freeze-dried EVs, such as their effect on cell 
proliferation and cell internalization, was studied in some of the studies 
(Table 2). Regardless of the importance of studying the endpoint results 
and comparing them to the fresh samples, all reported experiments lack 
in-line and on-line analysis. As we stated already in the introduction, 
this leads to considering freeze-drying as a black box. Taken together, it 
is important to study the quality of the product after freeze-drying and 
reconstitution, but that does not replace the importance of process 
control and in-line and on-line analysis. 
Freeze-drying of EVs requires excipients such as trehalose (the most 
frequently used) to prevent the vesicles' aggregation and destruction 
(Table 2). EVs freeze-dried with trehalose resembled EVs stored at 
− 80 ◦C by their size, morphology, and concentration [68,127–129]. In 
addition, trehalose protected proteins and RNA molecules inside EVs 
[68,129]. Furthermore, EVs freeze-dried with trehalose and stored at 
room temperature were reported to have similar in vivo pharmacoki-
netics as EVs stored at − 80 ◦C [129]. 
Frank et al. (2018) reported that they studied trehalose, mannitol, 
and polyethylene glycol (PEG) as lyoprotectants in the freeze-drying of 
EVs. Mannitol concentrations over 4% and PEG at all concentrations 
resulted in increased particle concentrations and aggregation of EVs, 
respectively, leaving trehalose as the most promising lyoprotectant with 
the concentration range of 0.5–5%. Mannitol and PEG provide me-
chanical strength and form the bulk for the samples. However, it seems 
that providing mechanical support for the EVs is insufficient alone to 
protect them from stress caused by freeze-drying. Nevertheless, me-
chanical support might be beneficial during storage and transportation. 
Fig. 9. Changing chemical, physical, and mechanical environments of biomaterials prior to freeze-drying affects their characteristics in the dried and reconstituted 
state. A) Freeze-dried nanofibrillated cellulose with excipients, B) freeze-dried nanofibrillated cellulose without excipients and C) freeze-dried chemically modified 
anionic nanofibrillated cellulose without excipients. Unpublished data. 
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There are no reports, to the best of our knowledge, on the use of 
directional freezing in the freeze-drying of EVs. In most studies, the 
freezing step was uncontrolled, suggesting a wide variation of local ice 
front velocities during freezing and an increased risk of damage. In 
conclusion, the effects of freezing on changes in the chemical, physical, 
and mechanical environment were not considered in any of the studies. 
We believe that the field of EVs conservation (both in the frozen state 
and freeze-dried) could strongly benefit from a more controlled freezing 
step. 
When EVs isolated from cerebrospinal fluid were freeze-dried 
without any additives, high, approximately 40%, reduction in the 
number of EVs was observed [126]. However, this is contrary to the 
results of Frank et al. (2018) who reported only minor changes in size 
and concentration of MSC and HUVEC derived EVs under comparable 
freeze-drying conditions [68]. These results highlight that EVs from 
different origins resist differently to the damage caused by freeze- 
drying. Although, applied techniques may impact the results [130]. 
EVs were mostly freeze-dried without controlling the shelf temper-
atures with benchtop freeze-driers overnight or 24 h [68,126,128,129]. 
Geeurickx et al. (2019) reported a freeze-drying cycle with clear freezing 
step, primary drying, and secondary drying. Surprisingly, there were no 
reports about the detection of Tg’ or collapsing temperatures in any 
paper, even though those temperatures are essential parameters when 
designing the freeze-drying cycle. However, no differences in properties 
of freeze-dried EVs resulting from the different freeze-drying cycles can 
be concluded. 
In our study, EVs were freeze-dried with excipients and a hydrogel 
scaffold (Fig. 10). We used a hydrogel scaffold in which the EVs were 
enveloped in the combination of nature origin excipients, such as sac-
charides. The idea of hydrogel scaffold is to prevent aggregation and 
fusion of EVs while the saccharides prevent damage caused by ice 
crystals and stabilize the lipid bilayer in a dry state similarly as with 
liposomes [131]. According to our results, the highest concentration was 
obtained when we addressed the chemical, physical, and mechanical 
environments accordingly. However, further optimization and evalua-
tion for example with biophotonic equipment is required. 
All freeze-dried EVs discussed in this review, except murine MSC 
derived EVs, were reconstituted by direct addition of distilled [126] or 
Milli-Q water [68,127]. Murine MSC derived EVs were reconstituted by 
incubating them in the water at 4 ◦C for 1 h [128]. As with the freeze- 
drying cycle, no differences in the results originating from the 
different rehydration methods can be concluded. Residual water content 
plays a major role in the shelf-life and preservation of biological sam-
ples. Thus, based on our opinion, it is worrying that the community has 
failed to report residual water contents of freeze-dried EV samples. 
Shelf-life studies of freeze-dried EVs varied from 7 days to 28 days 
and they were performed by subjecting the freeze-dried and stored EVs 
for similar experiments as before freeze-drying such as determining the 
protein and RNA contents and measuring the concentration of EVs 
[68,126,129]. Long-term stability experiments according to the general 
guidelines in the pharmaceutical industry are highly important and 
required to further evaluate the success and usefulness of freeze-drying 
for the preservation of EVs. This issue was also recognized by the groups 
who have been freeze-drying EVs [129]. 
5.3. Freeze-drying mammalian cells and biomaterial cell systems 
“Adult” desiccation-tolerant eukaryotic species such as Saccharo-
myces cerevisiae yeast or tardigrades are rare [132]. Consequently, 
freeze-drying of viable eukaryotic cells is far more challenging than 
freeze-drying of biomacromolecules, such as proteins, or liposomes, and 
EVs. Different aspects should be considered considering the planned 
usage of the freeze-dried cells: are the cells planned to be used as whole 
cells or just some parts of cells, such as DNA. In the case of freeze-drying 
and preserving whole cells, for example, the cell membrane must be 
protected, intracellular structures must be protected, and DNA must be 
protected. These can be addressed by adjusting the formulation with 
excipients to modulate the chemical environment, by controlling the 
freezing process and the physical environment, and by considering 
changes in the mechanical environment. 
Different kinds of cells have been freeze-dried and they are sum-
marized in Table 3. In addition, there are several reports about freeze- 
drying of mammalian spermatozoa and preserving the reproduction 
capacity of gametes [133,134], but those are left out of this review since 
we aim to focus on and review preservation of the more complicated 
systems. 
Freeze-drying of platelets and red blood cells typically aims to in-
crease the shelf-life of blood components essential for blood transfusion 
[141,142]. Considering the application, it is essential to formulate the 
freeze-drying formulation with biocompatible and non-toxic excipients 
such as sugars. Not surprisingly, trehalose has been the most used 
excipient in the freeze-drying of blood cells (Table 3). Platelets have 
been freeze-dried and stored for up to 22 months and their number, 
morphology, and aggregation capacity i.e. functionality, have been well 
preserved [142]. Trehalose and human serum albumin were the most 
important excipients. The importance of trehalose in the freeze-drying of 
platelets has been reported also by Zhou and colleagues [137,138], who 
reported that the highest recovery of human platelets was obtained 
when the platelets were freeze-dried with bovine serum albumin and 
trehalose. Furthermore, they state that also other sugars such as glucose, 
Table 2 
Excipients and freeze-drying methods used for extracellular vesicles and their 
characterization after freeze-drying. Note that no studies included PAT tools to 
analyze extracellular vesicles.  
























































































5% trehalose Uncontrolled 















A. Merivaara et al.                                                                                                                                                                                                                             
Journal of Controlled Release 336 (2021) 480–498
493
lactose, maltose, and sucrose serve as protecting excipients for platelets 
during freeze-drying. Hydrogen bonds provided by trehalose and su-
crose stabilize the cell structures while lactose and maltose, commonly 
used bulking agents, support the freeze-dried cells by providing extra-
cellular mechanical support. 
Red blood cells are needed in high numbers for blood transfusions. 
Especially in crisis areas where cold storage is impossible, increasing the 
shelf-life of red blood cells by freeze-drying, would increase their us-
ability, if the freeze-dried red blood cells can be used for the treatment 
by only adding water. Again, trehalose was the most used excipient in 
the freeze-drying for red blood cells as it was for the platelets. Extra-
cellular trehalose showed no protective effect in the preservation of 
hemoglobin of freeze-dried red blood cells [67]. However, when 
trehalose was loaded inside the cells by electroporation, trehalose 
showed beneficial effects on the preservation of red blood cells during 
freeze-drying [139]. Intracellular and extracellular presence of excipi-
ents is probably required to preserve the intracellular structures as well 
as lipid bilayer during freeze-drying. Furthermore, Arav and Natan 
(2012) showed the benefit of directional freezing in the freeze-drying of 
red blood cells [65]. However, the authors reported only up to 65% of 
water loss which makes it unclear what is the role of excipients, is long- 
term storage possible and can the samples be considered dry. 
Mononuclear cells, and hematopoietic progenitor and stem cells, 
both isolated from umbilical cord blood, have been freeze-dried 
[32,140]. Mononuclear cells' capacity to form colonies and viability of 
the cells were preserved when they were freeze-dried with antioxidant 
EGCG and frozen by directional freezing [32]. EGCG is reported to 
stabilize the lipid bilayer and this excipient alone was enough to protect 
the mononuclear cells during the freeze-drying when the freezing step 
was performed by directional freezing and controlling the freezing ve-
locity. The authors believe that the combination of correct excipients, 
number of cells, and directional freezing are all required for the pres-
ervation of the cells during and after freeze-drying. Hematopoietic 
progenitor cells were successfully freeze-dried with trehalose, human 
serum albumin, and hydroxyethyl starch [140]. Trehalose was loaded 
intracellularly by permeating the cell membrane via P2Z receptor with 
adenosine-5-triphosphate (ATP) and benzoyl ATP, to protect the cells 
from freeze-drying damage and to stabilize the cell membrane. The 
importance of intracellular and extracellular trehalose has been dis-
cussed also earlier with platelets and red blood cells [135,137,139]. 
In all freeze-drying studies performed with the mammalian cells, 
trehalose was the most used excipient. Some groups reported that they 
had loaded trehalose inside the cells to increase the protecting effects of 
that sugar [66,135–137,139,140]. Albumin, either human or bovine 
serum originated, was the second most used excipient in the freeze- 
drying of different cell types. Positive results were obtained when al-
bumin was used in the freeze-drying of blood cells [32,135–138]. 
However, albumin failed to preserve the viability and DNA integrity of 
mouse fibroblasts [64] but increases the Tg of dry formulations which is 
beneficial for storage at room temperature as there is less mobility in the 
sample when stored under Tg and the freeze-drying cake does not 
collapse [42,143]. Using albumin in combination with trehalose is one 
method to benefit from the properties of both excipients even though the 
exact mechanism, how albumin provides stabilization, is still unknown. 
Directional freezing was reported to be beneficial in the freeze- 
drying of red blood cells and mononuclear cells [32,65,141]. Ice front 
velocities were 0.2 mm/s and 1 mm/s for red blood cells and 0.02 mm/s, 
0.2 mm/s and 2 mm/s for mononuclear cells. Faster ice front velocity 
was beneficial in the freeze-drying of red blood cells while with mono-
nuclear cells, ice front velocity of 0.2 mm/s resulted in higher preser-
vation of proliferation capacities. Taken together, the optimal cooling 
rate or ice front velocity appears to be cell line dependent [44]. When 
optimizing freeze-drying in general, or freezing rates and ice front ve-
locities of biomaterials and cells, both cell line specific requirements and 
properties of the formulation must be carefully considered. 
How dry samples are after freeze-drying has a major impact on 
viability. This was studied ingeniously by Buchanan et al. (2010) in their 
study where they studied freeze-drying of hematopoietic progenitor 
cells and analyzed samples from different points of freeze-drying cycles. 
They showed that the proliferation and differentiation capacity of cells 
decreased as a function of the decreasing residual water content of cells. 
Their results are in line with previous reports concerning the importance 
of the role of the residual water content to cell viability [40]. Never-
theless, high residual water content does not automatically result in 
viable cells, which can be concluded from the experiments performed 
with freeze-drying of mouse fibroblasts [64]. 
Our group has freeze-dried encapsulated human retinal pigment 
epithelial cells ARPE 19 cells and 3D cultured human hepatocellular 
carcinoma (HepG2) cells [66,70]. The cells were loaded with trehalose 
and mechanically supported by biomaterial encapsulation and hydrogel 
scaffold, respectively. Encapsulated ARPE 19 cells and ARPE 19-Seap 
cells were freeze-dried with different saccharides (trehalose, dextran, 
sucrose) and glycerol [66]. The cells showed viability after rehydration; 
however, their oxygen consumption was highly reduced. For 3D HepG2 
cell spheroids, trehalose and glycerol were used as excipients and 
nanofibrillated cellulose hydrogel as a scaffold to provide mechanical 
Fig. 10. EVs were freeze-dried with different formulations consisting of a lyoprotective hydrogel scaffold or excipients, or a combination of those, and reconstituted 
with water. A) When EVs were freeze-dried in a lyoprotective scaffold with excipients, the total concentration of EVs was higher compared to the scaffold or ex-
cipients alone. The scaffold was removed before measurements. B) The size distribution indicates that the EVs tend to aggregate with the scaffold, but they are 
destroyed without the scaffold. The scaffold was removed before measurements. This is an example of the need for precise formulating with careful consideration of 
the chemical, physical, and mechanical environments when freeze-drying natural biomaterials such as EVs. EVs were analyzed with Nanoparticle tracking analysis. 
Biophotonic analysis methods such as Raman or FTIR spectroscopies would provide valuable information about freeze-dried EVs. Unpublished data. 
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Table 3 
Summary of freeze-dried cells, most important excipients, and main results. 
Recovery: Subjective feature that was characterized such as morphology, 
metabolic activity, or proliferation rate.  
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drying: 15 ◦C, 
10 h 
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N/A 18 [70] 
TRE = Trehalose; HSA = Human serum albumin; BSA = Bovine serum albumin; 
HES = Hydroxyethyl starch; NFC = Nanofibrillated cellulose; EGCG = Epi-
gallocatechin gallate. If different formulations were studied, the formulation 
with the highest recovery is reported here. 
a Intracellular trehalose concentration. 
b Continuing Wolkers et al. (2001) work, partly the same group. 
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support in the dry state [70]. We successfully preserved the 3D structure 
of HepG2 spheroids and partly enzymatic activity of the cell spheroids, 
but we failed to recover fully viable cell spheroids with intact cell 
membranes. Here again, the importance of controlling all the environ-
ments, chemical, physical, and mechanical, is of utmost importance. 
When we had no control over the physical parameters such as freezing 
rate and sublimation rate, the cytoskeleton of cells was destroyed. 
Contrary, when controlling the chemical, physical, and mechanical en-
vironments and considering the change of paradigm we are suggesting, 
the cytoskeleton of freeze-dried and reconstituted cell spheroids was 
preserved, and the dry aerogel scaffold appeared regular (Fig. 11). 
5.4. Future prospects of freeze-dried biomaterials, extracellular vesicles 
and cells 
As discussed in chapter 5.1. freeze-dried biomaterials are already in 
the market as hemostats and bone fillers. We believe that hybrid ma-
terials and biomaterials combined with active substances will be 
increasingly needed in clinical applications and the market. Freeze- 
drying is needed to manufacture the biomaterials and to preserve the 
active substances. 
The freeze-dried EVs are commercially offered as standard and 
reference materials, yet, no freeze-dried EVs are marketed for clinical 
usage, for example for drug delivery applications. Nevertheless, as the 
clinical applications of EVs develop further, we believe that also the 
understanding of freeze-drying must improve. 
With the cells, we have to first consider what the intended applica-
tion of the freeze-dried product is. If we consider pharmaceutical ap-
plications, such as drug metabolism experiments, potentially the 
preservation of the metabolizing enzymes can be already enough 
(compare to microsomes in drug metabolism studies). However, for 
more relevant in vitro experiments, the freeze-dried cells should be 
viable and functional. Another application of cells which we discussed, 
freeze-dried red blood cells for blood transfusion, would be highly 
beneficial in the catastrophe areas where cryopreservation is impossible 
and the need for blood transfusion is high. In that scenario, freeze-dried 
red blood cells stored at room temperature would outperform frozen 
blood products, but the production scale should be improved. 
One interesting method to preserve and encapsulate EVs and cells 
with increased drying efficiency would be spray freeze-drying. Spray 
freeze-drying has been utilized for preservation and encapsulation of a 
wide variety of products, such as small molecules, for oral and lung 
delivery, proteins for dermal delivery, and probiotic cells, as reviewed 
by Vishali et al. (2019) [144]. Spray freeze-drying provides a higher 
drying efficiency than freeze-drying and for example, it has enhanced 
the preservation and delivery of probiotic cells. To the best of our 
knowledge, spray freeze-drying has not been utilized with EVs or 
mammalian cells. 
The freeze-drying technology must develop in a more economic di-
rection, for freeze-dried cell products to become the standard way of 
preserving cells. Utilizing QbD ideology to carefully develop the process 
and carefully considering each environment in the freeze-drying, are the 
first steps to improve the process. In the future, as we are moving to ever 
greener technology and pharmacy, all the improvements in sustain-
ability will be of utmost importance. 
Fig. 11. Freeze-drying of cells and 3D cell spheroids is extremely challenging. A)-C) 3D cell spheroids freeze-dried with a hydrogel scaffold, and excipients, but 
without controlling the freezing rate or freeze-drying cycle. D)- F) 3D cell spheroids freeze-dried with the optimized method and considering the chemical, physical, 
and mechanical environments during the process. A) The cytoskeleton of the freeze-dried and reconstituted cell spheroid is destroyed. (Green: actin, Phalloidin Alexa 
488; Blue: nuclei, Hoechst 33342. B) The porous aerogel scaffold is irregular and damaged. C) Zoomed in SEM micrograph of a 3D cell spheroid after freeze-drying. 
D) The cytoskeleton of the 3D cell spheroid was preserved when the freeze-drying process was optimized and the different environments considered (Green: actin, 
Phalloidin Alexa 488; Blue: nuclei, Dapi). E) A 3D cell spheroid protected by the dry scaffold. The scaffold is porous with a regular structure. F) A zoomed-in SEM 
micrograph of freeze-dried 3D cell spheroid with intact 3D structure. A)-C): Auvinen et al. (2018) [70] D)-F): Unpublished data. (For interpretation of the references 
to colour in this figure legend, the reader is referred to the web version of this article.) 
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6. Conclusions 
Freeze-drying is a potential method to preserve the natural bio-
materials and cells in a dry state and to permit their storage preferably at 
room temperature, but to improve the results a change of paradigm is 
required. This change of paradigm involves the implementation of 
Quality-by-Design ideology and careful consideration of the chemical, 
physical, and mechanical environments before, during, and after freeze- 
drying. In particular, learnings that are emerging from other disciplines 
are important to consider. Furthermore, process analytical technology 
tools, such as biophotonic tools, are needed to monitor the samples 
during the process. We believe that by this change of paradigm the 
natural biomaterials and cells can be freeze-dried with even higher 
yields and freeze-drying applied into even more complex systems. 
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